Top

BY Scott Merville

Surveying the landscape of T cell presence and activity across the lungs of patients treated for localized non-small cell lung cancer, researchers have found that what matters most are T cells found in normal tissue.

When the tumor and uninvolved normal tissue elsewhere in the lung share high proportions of T cells, the immune response is less focused on the tumor and more distracted by the pursuit of viruses and other inflammatory...

Jianjun Zhang, M.D., Ph.D.

BY Scott Merville


An immunotherapy used against advanced non-small cell lung cancer is being tested at MD Anderson for a different...

BY Clayton Boldt, Ph.D.

November is Lung Cancer Awareness Month, and the third Thursday of each November is designated by the American Cancer Society as the Great...

BY Meagan Raeke

The recent outbreak of lung injury and death associated with e-cigarettes and vaping has led to a renewed scrutiny of electronic nicotine delivery systems (ENDS). While the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) are leading an investigation into e-cigarette, or vaping, associated lung injury (EVALI), available data on the short- and long-term health effects of ENDS are limited,...

”We still don’t fully understand the health consequences of the many, varied e-cigarettes and vaping devices that are currently marketed.” – MD Anderson Vice President of Cancer Prevention & Population Sciences Ernest Hawk, M.D.

BY Clayton Boldt, Ph. D.

Building upon the foundational discovery that the targeted therapy poziotinib is a potent and selective inhibitor of specific EGFR and HER2...

BY Clayton Boldt, Ph.D.

Repurposing FDA-approved therapies is a cost-effective way to bring new treatments to patients in need, but identifying those drugs with benefits...

BY Scott Merville

Small precancerous growths in the lungs are capable of progressing to invasive lung cancer, but so little has been known about them that understanding...

BY Ron Gilmore

Just as a driver’s night vision improves by simply cleaning the headlights, scientists at The University of Texas MD Anderson Cancer Center...

BY Scott Merville

MD Anderson researchers will present clinical trial results of promising combination therapies for a variety of cancers at the 2019 American...

BY Clayton R. Boldt, Ph.D.

MD Anderson’s proteomics platform provides a valuable institutional resource, complete with state-of-the-art instruments and specialized expertise...